-
Decision Resources: More patients switch to Onglyza from Merck's Type 2 diabetes drugs
BURLINGTON, Mass. Many Type 2 diabetes patients who use the drug Onglyza (saxagliptin) switched to that drug from Merck’s Januvia (sitagliptin) and Janumet (sitagliptin and metformin), according to a new report by market research firm Decision Resources.
-
Supervalu encourages healthy lifestyles with diabetes program
MINNEAPOLIS Supervalu on Thursday announced the launch of a comprehensive, whole-store health-and-wellness program called “living healthy with my diabetes.”
The program offers a variety of resources to make life easier for customers living with diabetes, including educational materials, health screening tests, group and individual diabetes education and training programs, medication management consultations, nutrition information, dietary tools, products and other services.